New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren’s become more severe over time and that the slow-to-progress disease likely starts long before it is first detected.
Small-cap companies lead the oncology pipeline by programmes in development
Figure 1: Number of oncology drugs by phase of development and by company market cap. Credit: GlobalData. It is common for biopharmaceutical companies that start
September 28, 2023